Eloy D. Hernandez

Statistics

Publications

Citations

489

H-Index

Active since

2014

Affiliations

Genomics Institute of the Novartis Research Foundation(Current)

Novartis (United States)

Sanford Burnham Prebys Medical Discovery Institute

Eloy D. Hernandez is an author at Genomics Institute of the Novartis Research Foundation specializing in liver disease, molecular biology, and signal transduction.

Publications per year

2014–2020

Publications

p62/SQSTM1 by Binding to Vitamin D Receptor Inhibits Hepatic Stellate Cell Activity, Fibrosis, and Liver Cancer

Ángeles Durán, Eloy D. Hernandez, Miguel Reina‐Campos et al. · Cancer Cell · 2016 · 249 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +12

Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic Steatohepatitis

D. CHIANELLI, Paul V. Rucker, Jason Roland et al. · Journal of Medicinal Chemistry · 2020 · 99 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

Tropifexor‐Mediated Abrogation of Steatohepatitis and Fibrosis Is Associated With the Antioxidative Gene Expression Profile in Rodents

Eloy D. Hernandez, Lianxing Zheng, Young Ho Kim et al. · Hepatology Communications · 2019 · 92 citations · Full text

Medicine, Biochemistry, Pharmacology +16

A Macrophage NBR1-MEKK3 Complex Triggers JNK-Mediated Adipose Tissue Inflammation in Obesity

Eloy D. Hernandez, Sang Jun Lee, Ji Young Kim et al. · Cell Metabolism · 2014 · 49 citations · Full text

Life Sciences, Immunology, Molecular Biology +10

1–4 of 4